Spinal cord injuries
Geron Corp., based in Menlo Park, Calif., expects to be the first U.S. company to test an embryonic stem cell treatment in a clinical trial.
The company has successfully injected neural cells - derived from animal embryonic stem cells - into mice with spinal cord lesions. The neural cells repaired the myelin, or coating around the nerve cells, allowing the nerve cells to function.
"Which means," said spokesman David Schull, "a paralyzed rat can walk."
He added: "We expect to complete the [investigational new drug] filing with the [Food and Drug Administration] by the end of year. The plan is to enter the clinic in 2008."
Tags: Geron Corp., Spinal Injury, ESC, Embryonic Stem Cells
Powered by Qumana
No comments:
Post a Comment